Most TSC caregivers plan to continue Epidiolex due to benefits like fewer seizures and improved cognition. New data at AES 2024 underscores Epidiolex's positive impact on TSC patients' health and well ...

- Medication indicated for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome, two rare, severe childhood-onset epilepsies - - Comprehensive support program available ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030 ...

Jazz Pharmaceuticals JAZZ initiated a new pivotal phase III study to evaluate its cannabidiol drug, Epidiolex/Epidyolex, for a new indication in epilepsy. This pivotal late-stage study will evaluate ...

Following release in March of positive topline results from a phase 3 trial of an investigational cannabidiol product (Epidiolex, GW Pharmaceuticals) in patients with Dravet syndrome, GW ...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a developer of cannabinoid prescription medicines, spiked by more than 10 percent Monday morning following the company's announcement that ...

Cannabis stock GW Pharma (GWPH) has announced that the US Food and Drug Administration (FDA) has approved Epidiolex oral solution for the treatment of seizures associated with tuberous sclerosis ...

The U.S. Food and Drug Administration’s recent historic approval of a plant-derived epilepsy drug whose main ingredient is cannabidiol (CBD) points to sweeping changes ahead for CBD-related business ...

The United States has approved, for the first time, a compound derived from marijuana to treat certain types of epilepsy. The ruling may spell good news for autism research. The approval of Epidiolex, ...

Though JAZZ Pharmaceuticals JAZZ is not your typical marijuana stock, it is an unconventional player in this field. The company entered the cannabis space after acquiring GW Pharmaceuticals in 2021, ...

The state’s hemp industry, which produces the majority of cannabidiol (CBD) products in Colorado, are worried about the consequences of a bill the General Assembly has approved that opens the door for ...